<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Earnings on FinanClub</title>
    <link>https://finan.club/tags/earnings/</link>
    <description>Recent content in Earnings on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 08 Mar 2024 09:03:05 +0000</lastBuildDate><atom:link href="https://finan.club/tags/earnings/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>MPW</title>
      <link>https://finan.club/us/mpw/</link>
      <pubDate>Fri, 08 Mar 2024 09:03:05 +0000</pubDate>
      
      <guid>https://finan.club/us/mpw/</guid>
      <description>score:6
Chances: Medical Properties Trust is making progress on its plan to get back on solid ground. The healthcare facilities landlord managed to please investors with its recent performance. MPW delivered FFO and revenue surprises for the quarter ended December 2023. Risks: Medical Properties Trust, Inc.</description>
    </item>
    
    <item>
      <title>ADM</title>
      <link>https://finan.club/us/adm/</link>
      <pubDate>Fri, 08 Mar 2024 09:02:58 +0000</pubDate>
      
      <guid>https://finan.club/us/adm/</guid>
      <description>score:-154
Chances: ADM is a well-established company with a long history in the production of agricultural commodities. The company&amp;rsquo;s diverse segments and end markets provide opportunities for growth and resilience. Potential for positive impact from the release of financial results for the fourth quarter of 2023.</description>
    </item>
    
    <item>
      <title>SWN</title>
      <link>https://finan.club/us/swn/</link>
      <pubDate>Thu, 07 Mar 2024 09:04:40 +0000</pubDate>
      
      <guid>https://finan.club/us/swn/</guid>
      <description>score:161
Chances: Higher institutional ownership implies stock price sensitivity Higher oil production and reduction in marketing purchases aiding Q4 earnings Longer-term bull case for natural gas and potential gainers Earnings and revenue surprises, strong cash flow despite lower commodity prices Risks: Stock price sensitivity to broader macroeconomic environment Impact of fluctuating gas output and supply on stock performance Score:161 chances characters count - risks characters count = 161</description>
    </item>
    
    <item>
      <title>TGTX</title>
      <link>https://finan.club/us/tgtx/</link>
      <pubDate>Fri, 01 Mar 2024 09:07:14 +0000</pubDate>
      
      <guid>https://finan.club/us/tgtx/</guid>
      <description>score:-39
Chances: TG Therapeutics beat earnings expectations in Q4 2023, indicating strong financial performance Sales of its multiple sclerosis treatment met expectations, leading to a surge in TGTX stock The issuance of additional patents by the USPTO extends the exclusivity of ublituximab through 2042, securing the company’s position in the market Risks: TG Therapeutics is not one of the most popular stocks among hedge funds, which may indicate lower investor confidence The company’s future revenue guidance for BRIUMVI is set between $220 - $260 million, and any deviation from this range could impact the stock price The launch of BRIUMVI in Europe by its ex-US partner introduces potential regulatory and market challenges Score:-39 chances characters count - risks characters count = -39</description>
    </item>
    
    <item>
      <title>GDRX</title>
      <link>https://finan.club/us/gdrx/</link>
      <pubDate>Fri, 01 Mar 2024 09:05:20 +0000</pubDate>
      
      <guid>https://finan.club/us/gdrx/</guid>
      <description>score:23
Chances: GoodRx beat Q4 estimates and issued strong guidance for 2024, indicating positive growth potential The company&amp;rsquo;s new stock buyback program valued at $450 million demonstrates confidence in its future performance GoodRx CEO Scott Wagner&amp;rsquo;s emphasis on industry innovation and the company&amp;rsquo;s leadership in AI technology bode well for future success Risks: Although revenue increased by 7%, the company encountered a net loss, indicating potential financial challenges The healthcare industry is subject to regulatory and market volatility, which may impact GoodRx&amp;rsquo;s performance Competition in the digital health sector poses a risk to GoodRx&amp;rsquo;s market position and profitability Score:23 chances characters count - risks characters count = 23</description>
    </item>
    
    <item>
      <title>AGL</title>
      <link>https://finan.club/us/agl/</link>
      <pubDate>Thu, 29 Feb 2024 09:02:50 +0000</pubDate>
      
      <guid>https://finan.club/us/agl/</guid>
      <description>score:0
Chances: Medicare Advantage Growth Soars as Company Adjusts to Rising Medical Costs The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended December 2023 The firm&amp;rsquo;s agilon Platform, provides healthcare for seniors across communities throughout the United States Risks: agilon health, inc.</description>
    </item>
    
    <item>
      <title>OKE</title>
      <link>https://finan.club/us/oke/</link>
      <pubDate>Wed, 28 Feb 2024 09:02:57 +0000</pubDate>
      
      <guid>https://finan.club/us/oke/</guid>
      <description>score:-59
Chances: ONEOK Inc reported higher fourth quarter and full-year 2023 results and provided optimistic 2024 financial guidance. The company plans to make investments in the range of $1.75-$1.9 billion in 2024 to strengthen its operation. ONEOK&amp;rsquo;s fourth-quarter earnings are likely to have gained from fee-based contracts and the completed acquisition of Magellan Midstream Partners.</description>
    </item>
    
    <item>
      <title>ARDX</title>
      <link>https://finan.club/us/ardx/</link>
      <pubDate>Tue, 27 Feb 2024 09:07:13 +0000</pubDate>
      
      <guid>https://finan.club/us/ardx/</guid>
      <description>score:112
Chances: Strong commercial performance of IBSRELA and XPHOZAH drive revenue surge for Ardelyx, Inc. The positive outlook for the U.S. economy and widespread analyst upgrades across various sectors reflect confidence in the economic backdrop. The global biotech market is set to experience exponential growth, providing a unique opportunity for savvy investors.</description>
    </item>
    
    <item>
      <title>WES</title>
      <link>https://finan.club/us/wes/</link>
      <pubDate>Fri, 23 Feb 2024 09:03:19 +0000</pubDate>
      
      <guid>https://finan.club/us/wes/</guid>
      <description>score:119
Chances: WES announced multiple divestment agreements that could lead to improved financial performance The strong earnings results for Q4 2023 indicate positive momentum for WES The upcoming UBS Global Energy &amp;amp; Utilities Conference could provide WES with an opportunity to showcase its potential Risks: The potential divestment of assets could impact WES&amp;rsquo;s future growth potential Any fluctuations in the energy market could affect WES&amp;rsquo;s operations and financial performance Score:119 chances characters count - risks characters count = 119</description>
    </item>
    
    <item>
      <title>DASH</title>
      <link>https://finan.club/us/dash/</link>
      <pubDate>Fri, 23 Feb 2024 09:02:53 +0000</pubDate>
      
      <guid>https://finan.club/us/dash/</guid>
      <description>score:237
Chances: DoorDash stock received an upgrade to Overweight from Equal-Weight at Morgan Stanley, signaling positive sentiment from analysts The company continues to deliver peer-leading and better-than-expected consumer spend and gross order value results, indicating strong performance across its expanding platform DoorDash&amp;rsquo;s 2023 Community Impact Report demonstrates positive impact on merchants, consumers, and Dashers, showing the company&amp;rsquo;s positive influence in the community Risks: DoorDash struggles to return to pre-pandemic levels of growth, trailing behind leading competitor Uber in key metrics The company missed on earnings expectations for Q4 2023, reporting an EPS of $-0.</description>
    </item>
    
    <item>
      <title>PPL</title>
      <link>https://finan.club/us/ppl/</link>
      <pubDate>Wed, 21 Feb 2024 09:07:58 +0000</pubDate>
      
      <guid>https://finan.club/us/ppl/</guid>
      <description>score:6
Chances: PPL&amp;rsquo;s fourth-quarter earnings are better than estimates and the company continues to make substantial investment to further strengthen its existing operations. Robust Capital Investment Plan and Dividend Growth Announced PPL&amp;rsquo;s estimated fair value is US$20.44 based on Dividend Discount Model Risks: PPL Corporation misses on earnings expectations.</description>
    </item>
    
    <item>
      <title>GTES</title>
      <link>https://finan.club/us/gtes/</link>
      <pubDate>Tue, 20 Feb 2024 09:05:53 +0000</pubDate>
      
      <guid>https://finan.club/us/gtes/</guid>
      <description>score:172
Chances: Gates Industrial Corp PLC&amp;rsquo;s CEO, Ivo Jurek, has increased the insider&amp;rsquo;s stake in the company by purchasing 20,492 shares, indicating confidence in the company&amp;rsquo;s potential growth. The company has been recognized as one of America&amp;rsquo;s Greatest Workplaces for Diversity 2024, showcasing its commitment to diversity and inclusion, which can enhance its reputation and attract top talent.</description>
    </item>
    
    <item>
      <title>ALKS</title>
      <link>https://finan.club/us/alks/</link>
      <pubDate>Fri, 16 Feb 2024 09:02:33 +0000</pubDate>
      
      <guid>https://finan.club/us/alks/</guid>
      <description>score:-21
Chances: Alkermes stock saw its Relative Strength Rating improve from 69 to 75, indicating a potential rebound in the stock&amp;rsquo;s performance. The company&amp;rsquo;s earnings and revenues outpaced estimates in the fourth quarter of 2023, driven by strong growth in proprietary products. Robust revenue growth and strategic focus are likely to propel Alkermes into 2024, indicating positive prospects for the company.</description>
    </item>
    
    <item>
      <title>IMGN</title>
      <link>https://finan.club/us/imgn/</link>
      <pubDate>Fri, 09 Feb 2024 09:02:41 +0000</pubDate>
      
      <guid>https://finan.club/us/imgn/</guid>
      <description>score:135
Chances: ImmunoGen has seen solid earnings estimate revision activity over the past two months,ImmunoGen (IMGN) might move higher on growing optimism about its earnings prospects ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Risks: AbbVie Inc. announced its plans to acquire ImmunoGen in an all-cash transaction valued at roughly $10.</description>
    </item>
    
    <item>
      <title>ARMK</title>
      <link>https://finan.club/us/armk/</link>
      <pubDate>Wed, 07 Feb 2024 09:03:14 +0000</pubDate>
      
      <guid>https://finan.club/us/armk/</guid>
      <description>score:-74
Chances: Aramark&amp;rsquo;s Q4 2023 earnings report indicates a stable performance, with revenue climbing 15% and operating income surging 37% The company&amp;rsquo;s dividend history, yield, and growth rates show potential for sustainable returns for investors The Food and Support Services United States (FSS United States) segment continues to offer food, hospitality and facility services for various institutions and venues, indicating a steady revenue stream Risks: Aramark&amp;rsquo;s Q1 2024 earnings call is approaching, and it&amp;rsquo;s essential to closely monitor key metrics and compare them with Wall Street estimates and year-ago numbers for any potential areas of concern While the company has seen decent share price growth, the economic environment can significantly impact its performance, posing a potential risk The company may face challenges related to specialized dietary and support services provided by the Food and Support Services International (FSS International) segment Score:-74 chances characters count - risks characters count = -74</description>
    </item>
    
    <item>
      <title>LBRT</title>
      <link>https://finan.club/us/lbrt/</link>
      <pubDate>Wed, 31 Jan 2024 09:06:36 +0000</pubDate>
      
      <guid>https://finan.club/us/lbrt/</guid>
      <description>score:47
Chances: The stock price of Liberty Energy Inc. (LBRT) is up by 14% this week, indicating positive momentum. The company announced full year and fourth quarter 2023 financial and operational results, suggesting potential growth and stability. The Board of Directors has increased its share repurchase authorization to $750 million, indicating confidence in the company&amp;rsquo;s future prospects.</description>
    </item>
    
    <item>
      <title>X</title>
      <link>https://finan.club/us/x/</link>
      <pubDate>Fri, 26 Jan 2024 09:02:36 +0000</pubDate>
      
      <guid>https://finan.club/us/x/</guid>
      <description>score:-22
Chances: U.S. Steel Corp. has the potential for a likely earnings beat in its upcoming report. Nippon Steel Corp. made an aggressive all-cash offer for United States Steel Corp., indicating potential for a high acquisition price. Risks: The acquisition bid from Nippon Steel Corp.</description>
    </item>
    
    <item>
      <title>JNJ</title>
      <link>https://finan.club/us/jnj/</link>
      <pubDate>Wed, 24 Jan 2024 09:08:15 +0000</pubDate>
      
      <guid>https://finan.club/us/jnj/</guid>
      <description>score:51
Chances: Johnson &amp;amp; Johnson beat fourth-quarter expectations with strong performance in the medtech segment. The company reported adjusted earnings of $2.29 per share, up 11.7% year-over-year, beating the consensus. Sales increased by 7.3% year-over-year to $21.4 billion, surpassing the consensus. Risks: Johnson &amp;amp; Johnson&amp;rsquo;s stock tumbled after the company reported lower profit margins in the medical device and technology unit last quarter.</description>
    </item>
    
    <item>
      <title>APP</title>
      <link>https://finan.club/us/app/</link>
      <pubDate>Wed, 24 Jan 2024 09:04:31 +0000</pubDate>
      
      <guid>https://finan.club/us/app/</guid>
      <description>score:-63
Chances: AppLovin has been hot, and the run higher might have some momentum. AppLovin (APP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company&amp;rsquo;s earnings prospects. Risks: It&amp;rsquo;s always important to assess the risk involved in investing in a company, especially in the volatile tech sector.</description>
    </item>
    
    <item>
      <title>DRH</title>
      <link>https://finan.club/us/drh/</link>
      <pubDate>Mon, 22 Jan 2024 09:04:27 +0000</pubDate>
      
      <guid>https://finan.club/us/drh/</guid>
      <description>score:-68
Chances: Wolfe Research initiated coverage of four hotel REITs this week, indicating potential opportunity in the sector. DiamondRock Hospitality Company is set to report financial results for the fourth quarter, providing insight into its performance. Comparable total revenues for DiamondRock Hospitality remain flat to 2022 and 12% higher than 2019, indicating potential stability and growth in the company.</description>
    </item>
    
    <item>
      <title>PAGS</title>
      <link>https://finan.club/us/pags/</link>
      <pubDate>Wed, 17 Jan 2024 09:07:20 +0000</pubDate>
      
      <guid>https://finan.club/us/pags/</guid>
      <description>score:231
Chances: PagSeguro (PAGS) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well. Brazil-focused fintechs, including PagSeguro, are thriving amid a strong economy, internet user growth and the unbanked. PagSeguro Digital Ltd.</description>
    </item>
    
  </channel>
</rss>
